Skip to main content

Table 1 (abstract P420)

From: Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients

Type of case ICU LOS (days) APACHE II Predicted mortality (%)
Total cases on enoxaparine 5.29 ± 7.3 16.7 ± 10.5 28.4 ± 23.7
Low platelets cases 11.75 ± 9.7 23 ± 2.3 48.75 ± 11.18
Major bleeding cases 13.5 ± 13.1 22.4 ± 17.4 30 ± 17.5